Voyager Therapeutics, Inc. (VYGR)
Nasdaq: VYGR · CIK 0001640266 · United States
Every official Voyager Therapeutics, Inc. filing in one place: annual reports, quarterly results, current reports,
proxy statements, shareholding and announcements, straight from the regulator. Free to search.
Open VYGR filings
Voyager Therapeutics, Inc. documents
- Voyager Therapeutics, Inc. 10-K 2026VYGR 10-K 2026: annual report for fiscal 2026
- Voyager Therapeutics, Inc. 10-K 2025VYGR 10-K 2025: annual report for fiscal 2025
- Voyager Therapeutics, Inc. 10-K 2024VYGR 10-K 2024: annual report for fiscal 2024
- Voyager Therapeutics, Inc. 10-K 2023VYGR 10-K 2023: annual report for fiscal 2023
- Voyager Therapeutics, Inc. 10-K 2022VYGR 10-K 2022: annual report for fiscal 2022
- Voyager Therapeutics, Inc. 10-Q 2026VYGR 10-Q 2026: quarterly report for fiscal 2026
- Voyager Therapeutics, Inc. 10-Q 2025VYGR 10-Q 2025: quarterly report for fiscal 2025
- Voyager Therapeutics, Inc. 10-Q 2024VYGR 10-Q 2024: quarterly report for fiscal 2024
- Voyager Therapeutics, Inc. 10-Q 2023VYGR 10-Q 2023: quarterly report for fiscal 2023
- Voyager Therapeutics, Inc. 10-Q 2022VYGR 10-Q 2022: quarterly report for fiscal 2022
- Voyager Therapeutics, Inc. 8-K 2026VYGR 8-K 2026: current report for fiscal 2026
- Voyager Therapeutics, Inc. 8-K 2025VYGR 8-K 2025: current report for fiscal 2025
- Voyager Therapeutics, Inc. 8-K 2024VYGR 8-K 2024: current report for fiscal 2024
- Voyager Therapeutics, Inc. 8-K 2023VYGR 8-K 2023: current report for fiscal 2023
- Voyager Therapeutics, Inc. 8-K 2022VYGR 8-K 2022: current report for fiscal 2022
- Voyager Therapeutics, Inc. DEF 14A 2026VYGR DEF 14A 2026: proxy statement for fiscal 2026
- Voyager Therapeutics, Inc. DEF 14A 2025VYGR DEF 14A 2025: proxy statement for fiscal 2025
- Voyager Therapeutics, Inc. DEF 14A 2024VYGR DEF 14A 2024: proxy statement for fiscal 2024
- Voyager Therapeutics, Inc. DEF 14A 2023VYGR DEF 14A 2023: proxy statement for fiscal 2023
- Voyager Therapeutics, Inc. DEF 14A 2022VYGR DEF 14A 2022: proxy statement for fiscal 2022
- Voyager Therapeutics, Inc. Form 4 2026VYGR Form 4 2026: insider trading filing for fiscal 2026
- Voyager Therapeutics, Inc. Form 4 2025VYGR Form 4 2025: insider trading filing for fiscal 2025
- Voyager Therapeutics, Inc. Form 4 2024VYGR Form 4 2024: insider trading filing for fiscal 2024
- Voyager Therapeutics, Inc. Form 4 2023VYGR Form 4 2023: insider trading filing for fiscal 2023
- Voyager Therapeutics, Inc. Form 4 2022VYGR Form 4 2022: insider trading filing for fiscal 2022
- Voyager Therapeutics, Inc. S-1 2026VYGR S-1 2026: registration statement for fiscal 2026
- Voyager Therapeutics, Inc. S-1 2025VYGR S-1 2025: registration statement for fiscal 2025
- Voyager Therapeutics, Inc. S-1 2024VYGR S-1 2024: registration statement for fiscal 2024
- Voyager Therapeutics, Inc. S-1 2023VYGR S-1 2023: registration statement for fiscal 2023
- Voyager Therapeutics, Inc. S-1 2022VYGR S-1 2022: registration statement for fiscal 2022
- Voyager Therapeutics, Inc. 13F 2026VYGR 13F 2026: institutional holdings for fiscal 2026
- Voyager Therapeutics, Inc. 13F 2025VYGR 13F 2025: institutional holdings for fiscal 2025
- Voyager Therapeutics, Inc. 13F 2024VYGR 13F 2024: institutional holdings for fiscal 2024
- Voyager Therapeutics, Inc. 13F 2023VYGR 13F 2023: institutional holdings for fiscal 2023
- Voyager Therapeutics, Inc. 13F 2022VYGR 13F 2022: institutional holdings for fiscal 2022
More companies